Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Jul;66(7):986-7.
doi: 10.1136/ard.2006.058784.

Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients

Case Reports

Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients

D Micheloud et al. Ann Rheum Dis. 2007 Jul.

Erratum in

  • Ann Rheum Dis. 2007 Aug;66(8):1128
No abstract available

PubMed Disclaimer

References

    1. Doria A, Iaccarino L, Sarzi‐Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 200514683–686. - PubMed
    1. D'Cruz D, Khamashta M, Hughes G R V. Cardiovascular manifestations of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. Philadelphia: Lippincott Williams &Wilkins, 2001645
    1. Houssiau F A, Vasconcelos C, D'Cruz D, Sebastiani G D, de Ramon Garrido E, Danieli M G.et al Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial. Arthritis Rheum 2004503934–3940. - PubMed
    1. Sherer Y, Shoenfeld Y. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus. Autoimmun Rev 20065153–155. - PubMed
    1. Sherer Y, Levy Y. Shoenfeld Y. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 199918238–240. - PubMed

Substances